COMMUNIQUÉS West-GlobeNewswire

-
Daxor CEO Michael Feldschuh to Engage Investors at Exclusive Maxim Growth Summit
21/10/2025 -
Notice convening an Extraordinary General Meeting of Novo Nordisk A/S
21/10/2025 -
Genmab Commences Tender Offer for All Issued and Outstanding Common Shares of Merus N.V.
21/10/2025 -
Sienna Announces The Opening of Its Long-Term Care Community Redevelopment in Brantford, Ontario
21/10/2025 -
Quoin Pharmaceuticals Announces U.S. FDA Grants Orphan Drug Designation for QRX003 in Netherton Syndrome
21/10/2025 -
Pacira BioSciences Notified of Abbreviated New Drug Application Filing from The WhiteOak Group for EXPAREL®
21/10/2025 -
Day One to Report Third Quarter 2025 Financial Results Tuesday, November 4, 2025
21/10/2025 -
SS Innovations to Participate in Upcoming Investor Conferences
21/10/2025 -
Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call
21/10/2025 -
Alpha Tau Announces Receipt of Radioactive Material License for its New Hampshire Manufacturing Facility, Advancing Towards Commercial Readiness
21/10/2025 -
CYIOS Corporation (OTC: CYIO) Announces Leadership Transition and Engages Artificial Intelligence (AI) and Software-as-a-Service (SaaS) advisors
21/10/2025 -
Fortress Biotech and Subsidiary Urica Therapeutics Announce First Patients Dosed in Crystalys Therapeutics’ Global Phase 3 Trials of Dotinurad for the Treatment of Gout
21/10/2025 -
Ultrack Systems Inc. (OTC: MJLB) Engages Empire Media Worx to Spearhead Major Rebranding and Market Expansion for Better Pets Division
21/10/2025 -
Consortium consisting of Nordic Capital and Permira lowers the minimum acceptance condition to 66 2/3% in respect of the takeover offer to the shareholders of Bavarian Nordic
21/10/2025 -
Recordati Launches 12th Edition of Arrigo Recordati Prize to Support Research in Paediatric Oncology
21/10/2025 -
Nexalin’s DIFS™ Neurostimulation Shows Cognitive and Brain Network Improvements in Alzheimer’s and Dementia Across Three Peer-Reviewed Studies
21/10/2025 -
Armada and Eclipse Energy Partner to Accelerate Commercialization of Critical Edge Technologies for Global Industrial Challenges
21/10/2025 -
WORK Medical Technology Group LTD Announces US$1 Million Equity Investment in Neologics Bioscience
21/10/2025 -
Dewpoint Therapeutics Announces an Open IND for First-in-Class Condensate Modulator DPTX3186 for Wnt-Driven Cancers
21/10/2025
Pages